Directed the net revenue forecasting (both demand and gross-to-net components), market research, and data-driven analytics informing the overall commercial and brand strategies within Tricida. Served as an integral member of the commercial launch team as the company builds up its capabilities for its Phase III product.- Maintained and improved upon the patient-based forecasting model and methodology.- Served as a key stakeholder in developing financial revenue recognition policies, particularly regarding gross-to-net accruals.- Managed and reported against an annual market research budget of over 4 million dollars, including post-launch initiatives around ATUs, promotional effectiveness, payer segmentation and utilization of prior authorizations.- Jointly led a launch strategy project to review marketing spend benchmarks.

Served as point for integration of legacy-Takeda and legacy-Shire price forecasting processes post-acquisition, striving for continuous improvement of internal processes to ensure quality, accuracy, and team adoption of best practices.- Transitioned legacy-Shire general medicine products to the legacy-Takeda price forecasting platform.- Directed the team in integration and harmonization of rebate data from the legacy organizations.- Built up team capabilities in Boston including collaboration with internal HR/external recruiters in recruiting and hiring as well as training and integration of new employees.

Managed up to four Managers/Senior Managers in short-, mid-, and long-term forecasting of pricing for general medicine, including several launch products, as well as a specialty product.- Personally built the team’s Excel-based forecasting model and reporting into a significantly more streamlined and efficient framework, shortening turnaround times associated with our planning cycles.- Forecasted contracted retail and non-retail discounts at the channel and individual payer levels as well as Medicare Part D coverage gap liability and Medicaid and PHS/340b pricing.- Led the implementation and modeling of commercial and Medicare Part D price protection.- Served as the primary representative of Contracts & Pricing in cross-functional planning meetings, working with brand leads, the volume forecasting/market research teams, Managed Markets, Finance, as well as the auditors. This included adapting the quarter close process to meet the stringent requirements of SOX compliance.- Performed variance analyses to forecast and distilled complex pricing forecasts into concise story lines for senior leadership.- Was responsible for a specialty drug with a focus on CMS ASP modeling and physician/provider reimbursement, value-based contracts, financial inputs for managed markets business cases, and well as launch planning for a subcutaneous formulation.- Participated in the recommendations on WAC pricing, taking into account individual therapeutic market conditions, competitive pricing, and financial return in the context of commercial price protection, NEP contracts, Medicaid CPI penalties, etc.

My position at TAP was absorbed into Abbott, with the majority of other positions being merged with Takeda.

Managed the short- and long-term forecasts (including life cycle management) for one of TAP’s two on-market products.- Led commercial business planning team (including brand marketing, finance, contracts and pricing, and sales management representatives) to identify and quantify historical trends in the marketplace as well as estimate the potential impact and probability of occurrence of market events for the near future.- In cooperation with the marketing group managers, led a separate cross-functional team (including managed markets, sales management, contracts & pricing, and research & development representatives) to develop, implement, and track core business strategies and tactics (including competitive intelligence).- Presented volume forecasts to senior management for key planning cycles—the annual commercial plan, mid-year review, and long-range plan.Managed quantitative and qualitative primary market research for an on-market product as well as a key Phase III pipeline product, both in the therapeutic area of men’s and women’s health.- Managed projects in the areas of physician segmentation, physician and patient positioning, competitive intelligence, patient insurance claims analysis, as well as other primary research with physicians, patients, and TAP sales representatives. Also assisted with brand name and packaging research.- Performed vendor identification, evaluation, and selection; questionnaire design; and interpretation and dissemination of the results of such projects.- Developed the market research plans for developmental products under my responsibility.

Worked with a field team that performed operational and clinical consulting for hospitals.- Focused on case management, assisting hospitals in identifying segments (specific diagnoses, specific physicians, short-stay patients) that exhibit the highest prevalence of patient overstays.- Performed operational analyses, including workload buildups to determine staffing requirements and related gap analyses to identify overstaffing.

Served as a sales and marketing consultant, working primarily in the pharmaceutical and health care industries.- Supported the marketing department of one of the top 10 pharmaceutical manufacturers in the world/U.S., including work in market research.- Optimized the sales force size and structure for a client with six sales force teams and 18 pharmaceutical products.- Aligned a U.S. sales force of eight regions and 75 territories.- Coordinated training for my 40-person Operations Research position.

Served as a programmer and then a business consultant to large state governmental agencies to implement financial accounting and human resources applications.